The Impact of AMNOG on Drug Reimbursement in Germany (Artikel)

Aus Kompetenzportal
Wechseln zu: Navigation, Suche
The Impact of AMNOG on Drug Reimbursement in Germany (Artikel)
Autor B. Heeg, O. Schoeman, Sabrina Müller, Thomas Wilke
In: Value in Health
Ausgabe 16 (7)
ISBN/ISSN:
Erscheinungsjahr 2013
Jahrgang November 2013
Seitenzahl A459
Hyperlink
Review

There are three main governmental stakeholders in the German AMNOG process: The IQWiG assesses the AMNOG drug manufacturer’s submission and provides advice on any additional benefit to the GBA who mak...